Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$10.67 - $14.43 $10,670 - $14,430
-1,000 Reduced 2.48%
39,346 $555,000
Q4 2023

Feb 12, 2024

SELL
$8.12 - $10.63 $148,596 - $194,529
-18,300 Reduced 31.2%
40,346 $421,000
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $3,119 - $4,461
417 Added 0.72%
58,646 $598,000
Q2 2023

Aug 03, 2023

BUY
$7.2 - $9.47 $187 - $246
26 Added 0.04%
58,229 $438,000
Q4 2022

Feb 09, 2023

BUY
$7.95 - $9.48 $3,180 - $3,792
400 Added 0.69%
58,203 $530,000
Q2 2022

Aug 05, 2022

SELL
$7.38 - $10.4 $2,214 - $3,120
-300 Reduced 0.52%
57,803 $434,000
Q1 2022

May 09, 2022

BUY
$7.33 - $9.39 $19,058 - $24,414
2,600 Added 4.68%
58,103 $546,000
Q4 2021

Feb 11, 2022

SELL
$7.9 - $10.19 $4,447 - $5,736
-563 Reduced 1.0%
55,503 $443,000
Q3 2021

Nov 12, 2021

BUY
$8.38 - $10.18 $6,285 - $7,635
750 Added 1.36%
56,066 $546,000
Q2 2021

Aug 12, 2021

BUY
$9.9 - $11.56 $547,628 - $639,452
55,316 New
55,316 $548,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.